GT Biopharma, Inc. - 8-K Filing
GT Biopharma raised $7.45M through a private placement offering of Series M convertible preferred stock and warrants on September 14, 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year)
Tickers: $GTBP